Allergan ' s Botox gets pediatric approval

Allergan announced that the U.S. FDA has approved the company ' s supplemental BLA for Botox for the treatment of pediatric patients (2 to 17 years of age) with lower limb spasticity, excluding spasticity caused by cerebral palsy.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news